$ESPR Esperion Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Esperion Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Esperion Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Esperion Therapeutics, Inc. for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ESPR
Company Address: 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR 48108
Phone number: 734-887-3903
Former name: HDL THERAPEUTICS INC, date of change: 2008-05-13
Market Capitalization: $454.22M
Prev close: $17.66
Average Daily Volume: 359,332
Days Low: $17.78
Year Low: $9.40
Year High: $20.75
Esperion Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | ESPR | Esperion Therapeut ... | Berkowitz Jeffrey | Director | Grant | A | 0.00 | 12,376 | 0 | 23,449 | 11.1 K to 23.4 K (+111.77 %) |
| May 28 2021 | ESPR | Esperion Therapeut ... | GOTTO ANTONIO M JR MD D PHIL | Director | Grant | A | 0.00 | 12,376 | 0 | 23,449 | 11.1 K to 23.4 K (+111.77 %) |
| May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.57 | 80,000 | 1,645,632 | 4,177,964 | 4.1 M to 4.2 M (+1.95 %) |
| May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.02 | 150,000 | 3,002,850 | 4,097,964 | 3.9 M to 4.1 M (+3.80 %) |
| Jan 29 2021 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | A | 32.12 | 175,000 | 5,621,000 | 175,000 | |
| Jan 29 2021 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Option Exercise | A | 32.12 | 50,000 | 1,606,000 | 50,000 | |
| Jan 29 2021 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 23,617 | 18.6 K to 23.6 K (+26.86 %) |
| Jan 29 2021 | ESPR | Esperion Therapeut ... | Hall Ashley | Chief Development O ... | Option Exercise | A | 32.12 | 31,000 | 995,720 | 31,000 | |
| Jan 29 2021 | ESPR | Esperion Therapeut ... | Hall Ashley | Chief Development O ... | Grant | A | 0.00 | 7,000 | 0 | 22,500 | 15.5 K to 22.5 K (+45.16 %) |
| Jan 29 2021 | ESPR | Esperion Therapeut ... | Koenig Sheldon L. | Chief Operating Off ... | Option Exercise | A | 32.12 | 150,000 | 4,818,000 | 150,000 | |
| Jan 29 2021 | ESPR | Esperion Therapeut ... | Koenig Sheldon L. | Chief Operating Off ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Dec 31 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | M | 2.10 | 10,700 | 22,427 | 262,959 | |
| Dec 31 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | M | 2.10 | 10,700 | 22,427 | 122,698 | 112 K to 122.7 K (+9.55 %) |
| Nov 04 2020 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 25.31 | 200,000 | 5,062,120 | 3,947,964 | 3.7 M to 3.9 M (+5.34 %) |
| May 29 2020 | ESPR | Esperion Therapeut ... | Berkowitz Jeffrey | Director | Grant | A | 0.00 | 6,106 | 0 | 11,073 | 5 K to 11.1 K (+122.93 %) |